Flexion Therapeutics, a developer of innovative therapeutics for musculoskeletal disorders, has relocated its corporate headquarters to 10 Burlington Mall Rd., owned by Boston Properties. In a substantial expansion, Flexion is moving from 300 Trade Center in Woburn.
The company leased 11,754 s/f of office space in the 58,558 s/f building, which is owned by Boston Properties. Terms of the deal were not disclosed.
Flexion is developing three novel drug candidates, each of which represents a distinct mechanism of action. Together, these products have the potential to treat mild, moderate and severe forms of osteoarthritis and to slow disease progression.
The Shaffer Company represented Flexion while Avison Young represented Boston Properties.